The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

C. Yurdaydin; R. Idilman; C. Kalkan; M. F. Karakaya; A. Caliskan; O. Keskin; E. Yurdcu; S. C. Karatayli; M. Bozdayi; C. Koh; T. Heller; J. Glenn

doi:10.1016/S0168-8278(17)30828-0

The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

C. Yurdaydin
, R. Idilman
, C. Kalkan
, M. F. Karakaya
, A. Caliskan
, O. Keskin
, E. Yurdcu
, S. C. Karatayli
, M. Bozdayi
, C. Koh
, T. Heller
, J. Glenn

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S259-S259
Number of pages	1
Journal	Journal of Hepatology
Volume	66
Issue number	1
DOIs	https://doi.org/10.1016/S0168-8278(17)30828-0
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0168-8278(17)30828-0

Cite this

Yurdaydin, C., Idilman, R., Kalkan, C., Karakaya, M. F., Caliskan, A., Keskin, O., Yurdcu, E., Karatayli, S. C., Bozdayi, M., Koh, C., Heller, T., & Glenn, J. (2017). The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis. Journal of Hepatology, 66(1), S259-S259. https://doi.org/10.1016/S0168-8278(17)30828-0

@article{76ca49dcafe141d2bacbde2ab604781c,

title = "The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis",

author = "C. Yurdaydin and R. Idilman and C. Kalkan and Karakaya, \{M. F.\} and A. Caliskan and O. Keskin and E. Yurdcu and Karatayli, \{S. C.\} and M. Bozdayi and C. Koh and T. Heller and J. Glenn",

year = "2017",

doi = "10.1016/S0168-8278(17)30828-0",

language = "English",

volume = "66",

pages = "S259--S259",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "1",

}

Yurdaydin, C, Idilman, R, Kalkan, C, Karakaya, MF, Caliskan, A, Keskin, O, Yurdcu, E, Karatayli, SC, Bozdayi, M, Koh, C, Heller, T & Glenn, J 2017, 'The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis', Journal of Hepatology, vol. 66, no. 1, pp. S259-S259. https://doi.org/10.1016/S0168-8278(17)30828-0

TY - JOUR

T1 - The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

AU - Yurdaydin, C.

AU - Idilman, R.

AU - Kalkan, C.

AU - Karakaya, M. F.

AU - Caliskan, A.

AU - Keskin, O.

AU - Yurdcu, E.

AU - Karatayli, S. C.

AU - Bozdayi, M.

AU - Koh, C.

AU - Heller, T.

AU - Glenn, J.

PY - 2017

Y1 - 2017

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000401056600565&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1016/S0168-8278(17)30828-0

DO - 10.1016/S0168-8278(17)30828-0

M3 - Meeting Abstract

SN - 0168-8278

VL - 66

SP - S259-S259

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 1

ER -

The prenylation inhibitor lonafarnib can induce post-treatment viral clearance in patients with chronic delta hepatitis resulting in alt normalization and regression of fibrosis

UN SDGs

Access to Document

Other files and links

Cite this